» Articles » PMID: 29373838

Quantifying Multiple Sclerosis Pathology in Post Mortem Spinal Cord Using MRI

Overview
Journal Neuroimage
Specialty Radiology
Date 2018 Jan 27
PMID 29373838
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis (MS) is a common inflammatory, demyelinating and degenerative disease of the central nervous system. The majority of people with MS present with symptoms due to spinal cord damage, and in more advanced MS a clinical syndrome resembling that of progressive myelopathy is not uncommon. Significant efforts have been undertaken to predict MS-related disability based on short-term observations, for example, the spinal cord cross-sectional area measured using MRI. The histo-pathological correlates of spinal cord MRI changes in MS are incompletely understood, however a surge of interest in tissue microstructure has recently led to new approaches to improve the precision with which MRI indices relate to underlying tissue features, such as myelin content, neurite density and orientation, among others. Quantitative MRI techniques including T and T, magnetisation transfer (MT) and a number of diffusion-derived indices have all been successfully applied to post mortem MS spinal cord. Combining advanced quantification of histological features with quantitative - particularly diffusion-based - MRI techniques provide a new platform for high-quality MR/pathology data generation. To more accurately quantify grey matter pathology in the MS spinal cord, a key driver of physical disability in advanced MS, remains an important challenge of microstructural imaging.

Citing Articles

Spinal cord evaluation in multiple sclerosis: clinical and radiological associations, present and future.

Keegan B, Absinta M, Cohen-Adad J, Flanagan E, Henry R, Klawiter E Brain Commun. 2024; 6(6):fcae395.

PMID: 39611182 PMC: 11604059. DOI: 10.1093/braincomms/fcae395.


Neurological complications in oncology and their monitoring and management in clinical practice: a narrative review.

Fischer S, von Bonin M, Bornhauser M, Beste C, Ziemssen T Support Care Cancer. 2024; 32(10):685.

PMID: 39317778 PMC: 11422253. DOI: 10.1007/s00520-024-08894-5.


Advanced spinal cord MRI in multiple sclerosis: Current techniques and future directions.

Combes A, Clarke M, OGrady K, Schilling K, Smith S Neuroimage Clin. 2022; 36:103244.

PMID: 36306717 PMC: 9668663. DOI: 10.1016/j.nicl.2022.103244.


CEST MRI and MALDI imaging reveal metabolic alterations in the cervical lymph nodes of EAE mice.

Thomas A, Yang E, Smith M, Chu C, Calabresi P, Glunde K J Neuroinflammation. 2022; 19(1):130.

PMID: 35659311 PMC: 9164344. DOI: 10.1186/s12974-022-02493-z.


High-resolution quantitative MRI of multiple sclerosis spinal cord lesions.

McDowell A, Petrova N, Carassiti D, Miquel M, Thomas D, Barker G Magn Reson Med. 2022; 87(6):2914-2921.

PMID: 35014736 PMC: 9208576. DOI: 10.1002/mrm.29152.